The study in a mouse model of colonic carcinogenesis showed that oral intake of probiotics containing lactobacilli can reduce IL-17-producing T cells and inhibit proliferation and tumor formation, which may be achieved by changing the gut microbiome. The gene discussed is IL17A; the disease is neoplasm.